Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Study Demonstrating Lurasidone Is Effective In Patients With Schizophrenia Published In The Journal Of Clinical Psychiatry
Dainippon Sumitomo Pharma Co., Ltd., (DSP) announced that positive results from a phase 2 clinical trial for lurasidone in the treatment of patients with schizophrenia have been published in The Journal of Clinical Psychiatry. This six-week, randomized, double-blind, multicenter, placebo-controlled trial, involving 180 patients with acute schizophrenia, evaluated a single fixed dose of lurasidone 80 mg/day versus placebo. Lurasidone 80 mg/day produced statistically significant improvement versus placebo in both primary and secondary efficacy assessments at all study visits starting at day 3. In addition, lurasidone was generally well-tolerated and was associated with weight and metabolic changes that were similar to placebo.

African Institutions Lead International Consortia In $49 Million Initiative
More than fifty institutions from eighteen African countries - from Senegal to Sudan to South Africa - are to participate in international consortia under a ÷£30 million initiative from the Wellcome Trust to strengthen research capacity on the continent.
News of the day
Projected Food, Energy Demands Seen To Outpace Production
With the caloric needs of the planet expected to soar by 50 percent in the next 40 years, planning and investment in global agriculture will become critically important, according a new report released recently.
Sexual Health

MS Society Scotland Supports Shine On Scotland Campaign

The MS Society Scotland has backed a school boy from Glasgow whose campaign aims to seek support for the use of vitamin D in helping to prevent the onset of multiple sclerosis (MS). Ryan McLaughlin"s campaign "Shine on Scotland" was launched in April 2009 after the MS Society announced that research funded by the charity had discovered vitamin D deficiency during pregnancy and the early years could potentially increase the risk of developing MS later in life. Ryan"s mother has MS and the 14 year old launched the campaign in an effort to help prevent future generations developing the condition. The campaign has three aims: - to encourage the Scottish Government to provide vitamin D to all of Scotland"s children and pregnant mothers - to seek clarification on the recommended daily allowance of vitamin D - to run a public awareness campaign to inform people of the benefits of vitamin D in relation to MS An e-petition has been launched and Ryan is now seeking to recruit over 500 children willing to march the Royal Mile in Edinburgh on June 16 to Scottish Parliament to hand in the petition. MS Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009